Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABP1011T in Advanced Solid Tumors (Phase IIb, Open-label, Multi-cohort)
CTR20254452Phase 2Active
- Sponsor
- EyeBio
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ABP1011T in Nonhematologic neoplasms, small cell lung cancer (SCLC), esophageal cancer, Cervical Cancer (CC), bladder cancer, sponsored by EyeBio. Started Dec 2025; status: active.
02
Drugs
ABP1011T
03
Conditions
Nonhematologic neoplasmssmall cell lung cancer (SCLC)esophageal cancerCervical Cancer (CC)bladder cancer
Beyond the preview
Go deeper on CTR20254452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254452.